Rodrigo Machado-Vieira
Rodrigo Machado-Vieira is an expert in Psychiatry at The University of Texas Health Science Center at Houston (United States). As of October 2026, ScienceLeadR ranks Rodrigo Machado-Vieira in the top 1% of experts worldwide for Mood Disorders. Rodrigo Machado-Vieira has authored 217 publications, the most recent in 2026, and is an investigator in 16 clinical trials. SLR score: 795 (community average: 125). How the SLR is computed.
LeadR Profile
Psychiatry
Subspecialties: Pharmacy - Neurology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 217
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| INSIGHTFUL: insight generation through clinical annotation, analysis and modelling of suicide-related factors towards understanding and lifesaving. PMID 42712291 — language, safety, multiple chronic conditions, classification, artificial intelligence, self-injurious behavior, suicide | BMJ Digit Health Ai | 2025 | 2 |
| Low-dose lithium, neuroprotection, and brain aging in bipolar disorder. PMID 42581099 — bipolar disorder, aging, brain, neuroprotection | Neuropsychopharmacology | 2026 | 0 |
| Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics. PMID 42521762 — cytokines, interferon-gamma, antidepressive agents, cells, interleukin-15, molecular biology, mental disorders, ketamine, hallucinogens, neurosciences, therapeutics, lysergic acid diethylamide, plasma | Mol Psychiatry | 2026 | 0 |
| Establishing a Specialty Bipolar Clinic: The National Network of Depression Centers Consensus Recommendations. PMID 42429592 — depression, bipolar disorder, treatment adherence and compliance, psychosocial intervention | Bipolar Disord | 2026 | 0 |
| Response-predictive MRI biomarkers of low-dose lithium therapy: cortical thickness changes in patients with bipolar depression. PMID 42184576 — depression, biomarkers, diagnostic imaging, therapeutics, psychiatry | Psychiatry Res Neuroimaging | 2026 | 0 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map